• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fabino Enterprises Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 76237.0
  • ISIN : INE0DRT01018
26.00 0 (0.00%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    26.00

  • Today’s High

    26.00

  • Open

    26.00

  • Perv Close

    26.00

  • 52W Low

    22.80

  • 52W High

    38.96

Key Indicators

  • P/E(TTM)

    41.27

  • Mar.Cap (₹Cr.)

    5.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.43

  • Debt-Equity Ratio

    0.00

  • AGM Date

    08-Aug-2025

  • EPS

    0.63

  • P/E Ratio

    41.27

Financials Ratios

  • Debt-Equity Ratio

    0.20

  • Mar.Cap (₹Cr.)

    5.46

  • RONW (%)

    0.97

  • ROCE (%)

    1.80

Score Board

  • Equity (₹ in Cr.)

    2.10

  • BV (₹)

    20.40

  • Sales( ₹ in Cr.)

    18.04

  • NP (in Cr.)

    0.13

  • NP Var(%)

    177.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    5.46

  • 52 Week High

    38.96

  • 52 Week Low

    22.80

  • Price BSE

    26.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    5.46

  • P/C Ratio

    27.60

  • P/E Ratio

    41.40

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 6.08 3.36 4.20 3.06 7.52 2.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6.08 3.36 4.20 3.06 7.52 2.76
Other Income 0.29 0.02 0.01 0.00 0.00 0.00
Stock Adjustments -0.15 -0.52 1.24 0.17 -4.63 0.62
Total Income 6.22 2.86 5.45 3.23 2.89 3.38
EXPENDITURE :            
Raw Materials 5.63 2.43 4.81 2.91 2.26 2.44
Power and Fuel Cost 0.00 0.01 0.00 0.03 0.00 0.00
Employee Cost 0.16 0.19 0.19 0.09 0.21 0.30
Other Manufacturing Expenses 0.05 0.00 0.02 0.00 0.00 0.03
Selling and Administration Expenses 0.17 0.15 0.31 0.13 0.00 0.00
Miscellaneous Expenses 0.12 0.02 0.01 0.02 0.10 0.29
Employee Benefit Expenses 0.16 0.19 0.19 0.09 0.21 0.30
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.13 2.81 5.35 3.17 2.57 3.06
Operating Profit 0.11 0.05 0.11 0.07 0.32 0.32
Interest 0.02 0.01 0.01 0.01 0.20 0.29
Gross Profit 0.09 0.04 0.10 0.06 0.12 0.03
Depreciation 0.03 0.03 0.03 0.02 0.02 0.03
Profit Before Tax 0.06 0.01 0.07 0.04 0.10 0.00
Current Tax 0.01 0.00 0.02 0.01 0.03 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.05 0.01 0.05 0.03 0.07 0.00
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.05 0.01 0.05 0.03 0.07 0.00
Adjustment below Net Profit -0.01 0.00 0.00 -0.05 0.00 0.00
P & L Balance brought forward 0.16 0.15 0.10 0.12 0.05 0.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.20 0.16 0.15 0.10 0.12 0.05
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.23 0.05 0.22 0.25 4.59 0.01
Earnings Per Share(Adj)-Unit Curr - 0.05 0.22 - - -
Book Value 19.80 19.59 19.54 10.86 44.84 40.25
Book Value(Adj)-Unit Curr - 19.59 19.54 - - -

Shareholding Pattern

  • Promoter Group

    56.82%

  • Public Share Holding

    43.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 93,200 4.44 93,200 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,100,000 52.38 1,100,000 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,193,200 56.82 1,193,200 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 252,000 12.00 252,000 6
Clearing Members 21,000 1.00 21,000 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 9,000 0.43 9,000 2
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 12,000 0.57 12,000 4
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 168,000 8.00 168,000 7
Individuals holding nominal share capital up to Rs. 1 lakh 444,800 21.18 444,800 111
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 906,800 43.18 906,800 132
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,100,000 100.00 2,100,000 137

Company Background

Fabino Enterprises LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Fabino Enterprises Ltd
  • BSE Code : 76237.0
  • ISIN : INE0DRT01018

  • Incorporation Year

    2011

  • Registered Office

    105 1st Floor Barodia Tower
    Central Market Prashant Vihar, New Delhi,
    New Delhi-110085

  • Telephone

    +91-988390021/9215324221

  • FAX

  • Chairman

  • Managing Director

    Aditya Mahavir Jain

  • Company Secretary

  • Auditor

    D G M S & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar


    ,
    ,
    Mumbai -

Fabino Enterprises Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fabino Enter 26.00 6.38 6.08 41.27 1.88
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10